Polar Capital Holdings’s Roivant Sciences ROIV Stock Holding History

Polar Capital Holdings’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.7M	Sell	1,376,554 -201,754	-13%	-$5.96M	0.12%	127
2026 Q1	$43.7M	Sell	1,578,308 -1,111,816	-41%	-$28.6M	0.16%	108
2025 Q4	$58.4M	Buy	2,690,124 +731,389	+37%	+$14.4M	0.23%	87
2025 Q3	$29.6M	Buy	1,958,735 +733,735	+60%	+$9.08M	0.14%	118
2025 Q2	$13.8M	Sell	1,225,000 -1,275,000	-51%	-$13.8M	0.07%	167
2025 Q1	$25.2M	Sell	2,500,000 -1,000,000	-29%	-$10.8M	0.15%	134
2024 Q4	$41.4M	Hold	3,500,000	–	–	0.23%	109
2024 Q3	$40.4M	Buy	3,500,000 +2,000,000	+133%	+$22.8M	0.19%	104
2024 Q2	$15.9M	Hold	1,500,000	–	–	0.09%	157
2024 Q1	$15.8M	Buy	+1,500,000	New	+$16.2M	0.08%	164

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Polar Capital Holdings's ROIV Position: Q2 2026 in Review

Polar Capital Holdings reduced its Roivant Sciences (ROIV) stake by 13% in Q2 2026, selling an estimated $5.96M and leaving 1,376,554 shares worth $48.7M. The position accounts for 0.12% of the portfolio, ranked #127.

Polar Capital Holdings first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. The position peaked at $58.4M in Q4 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Polar Capital Holdings held 1,376,554 shares of Roivant Sciences worth $48.7M as of Q2 2026.
Polar Capital Holdings sold 201,754 Roivant Sciences shares in Q2 2026, an estimated $5.96M.
Roivant Sciences made up 0.12% of Polar Capital Holdings's portfolio in Q2 2026, its #127 holding.
Polar Capital Holdings first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
Polar Capital Holdings's Roivant Sciences position peaked at $58.4M in Q4 2025.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.